Kazia Therapeutics earnings were -$13.4M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest KZIA earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, KZIA reported annual earnings of -$13.6M, with -23.7% growth.
What were Kazia Therapeutics's earnings last quarter?
Kazia Therapeutics (NASDAQ: KZIA) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total KZIA earnings for the quarter were N/A. In the same quarter last year, Kazia Therapeutics's earnings per share (EPS) was N/A.
As of the last Kazia Therapeutics earnings report, Kazia Therapeutics is currently losing money. Kazia Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$13.62 million, a 23.71% decrease year over year.
What was KZIA's earnings growth in the past year?
As of Kazia Therapeutics's earnings date in Q4 2025, Kazia Therapeutics's earnings has grown year over year. KZIA earnings in the past year totalled -$13.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.